Your Health. Your Family. Your Choice.
Life Threatening? No
Write-up: This case was reported by a regulatory authority and described the occurrence of intussusception in a 3-month-old male subject who was vaccinated with ROTARIX (GlaxoSmithKline). No concomitant medication was reported. On 17 March 2008, the subject received unspecified dose of ROTARIX (oral), lot number not provided. Two days prior to the event onset, the 2 subject''s siblings experienced gastroenteritis. On 18 April 2008, 32 days after vaccination with ROTARIX, the subject experienced intussusception. The regulatory authority reported that the event was clinically significant (or requiring intervention). The subject was treated with surgery. No structural anomaly was detected. At the time of reporting the event was resolved. The regulatory authority reported that the event was probably related to vaccination with ROTARIX.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166